Pharmacokinetics of apigenin solid lipid nanoparticles in rats

LIU Ren,HU Hai-yang,Hu Chan-juan,CHEN Da-wei,LIU Dan,ZHAO Xiu-li
2009-01-01
Abstract:Objective To study the pharmacokinetics and bioavailability of apigenin solid lipid nanoparticles after peroral administration in rats. Methods The plasma concentration of apigenin in rats was determined by HPLC following oral administration of apigenin solid lipid nanoparticles and suspensions. Results The pharmacokinetics of the tested preparation and apigenin suspension conform to one-compartment model, with the relative bioavailability of 325% for apigenin solid lipid nanoparticles compared to that of the suspension. Conclusions The bioavailability of apigenin can be significantly improved by incorporating it into solid lipid nanoparticles. Therefore, solid lipid nanoparticles can be used to improve the oral bioavailability of poorly soluble drugs.
What problem does this paper attempt to address?